Proposed Data Collections Submitted for Public Comment and Recommendations, 1688-1689 [E9-405]
Download as PDF
<![CDATA[
1688
Federal Register / Vol. 74, No. 8 / Tuesday, January 13, 2009 / Notices
ORIGINAL THRESHOLD
ADJUSTED THRESHOLD
$200 million
$260.7 million
$500 million
$651.7 million
$1 billion
$1,303.4 million
EFFECTIVE DATE:
February 12, 2009.
FOR FURTHER INFORMATION CONTACT: B.
Michael Verne, Bureau of Competition,
Premerger Notification Office (202) 3263100.
Authority: 16 U.S.C. § 7A.
Centers for Disease Control and
Prevention
ACTION:
Revised Jurisdictional Thresholds for
Section 8 of the Clayton Act
Federal Trade Commission.
Notice.
SUMMARY: The Federal Trade
Commission announces the revised
thresholds for interlocking directorates
required by the 1990 amendment of
Section 8 of the Clayton Act. Section 8
prohibits, with certain exceptions, one
person from serving as a director or
officer of two competing corporations if
two thresholds are met. Competitor
corporations are covered by Section 8 if
each one has capital, surplus, and
undivided profits aggregating more than
$10,000,000, with the exception that no
corporation is covered if the competitive
sales of either corporation are less than
$1,000,000. Section 8(a)(5) requires the
Federal Trade Commission to revise
those thresholds annually, based on the
change in gross national product. The
new thresholds, which take effect
immediately, are $26,161,000 for
Section 8(a)(1), and $2,616,100 for
Section 8(a)(2)(A).
FOR FURTHER INFORMATION CONTACT:
James F. Mongoven, Bureau of
Competition, Office of Policy and
Coordination, (202) 326-2879.
Section 301–10.122 of the Federal
Travel Regulation (FTR) (41 CFR 301–
10.122) stipulates that Federal
employees, with few exceptions, must
use coach-class accommodations. As a
result of many airlines now charging
additional fees for checked baggage, as
well as for seat choice in the coach-class
cabin, this bulletin was developed to
clarify which of these fees may be
reimbursed by Federal agencies.
B. Procedures
Proposed Project
Assisted Reproductive Technology
(ART) Program Reporting System—
Revision—National Center for Chronic
Disease Prevention and Health
Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).
DATES: The bulletin announced in this
notice became effective on December 31,
2008, and will remain effective until the
FTR is amended to reflect the changes.
FOR FURTHER INFORMATION CONTACT: For
clarification of content, please contact
Mr. Cy Greenidge, Office of
Governmentwide Policy, Office of
Travel, Transportation and Asset
Management, at (202) 219–2349.
Please cite FTR Bulletin 09–02.
SUPPLEMENTARY INFORMATION:
A. Background
Donald S. Clark,
Secretary.
[FR Doc. E9–418 Filed 1–12–09; 8:45 am]
BILLING CODE 6750–01–S
BILLING CODE 6820–14–P
By direction of the Commission.
VerDate Nov<24>2008
19:12 Jan 12, 2009
Jkt 217001
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–5960 and
send comments to Maryam I. Daneshvar,
CDC Acting Reports Clearance Officer,
1600 Clifton Road, MS–D74, Atlanta,
GA 30333 or send an e-mail to
omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
This Bulletin informs
agencies what baggage and seat choice
fees they may reimburse their
employees while on official travel. GSA
Bulletin FTR 09–02 may be found at
https://www.gsa.gov/bulletin.
Dated: January 5, 2009.
Russell H. Pentz,
Assistant Deputy Associate Administrator,
Office of Travel, Transportation, and Asset
Management.
[FR Doc. E9–434 Filed 1–12–09; 8:45 am]
Authority: 15 U.S.C. § 19(a)(5).
[60 Day–09–0556]
Bulletins regarding the Federal Travel
Regulation are located on the Internet at
https://www.gsa.gov/bulletin as Federal
Travel Regulation bulletins.
FEDERAL TRADE COMMISSION
January 13, 2009.
Notice of a bulletin.
SUMMARY:
BILLING CODE 6750–11–S
EFFECTIVE DATE:
Federal Travel Regulation (FTR);
Notice of GSA Bulletin FTR 09–02
Office of Governmentwide
Policy, General Services Administration
(GSA).
Donald S. Clark,
Secretary.
[FR Doc. E9–411 Filed 1–12–09; 8:45 am]
ACTION:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
AGENCY:
By direction of the Commission.
AGENCY:
GENERAL SERVICES
ADMINISTRATION
PO 00000
Frm 00027
Fmt 4703
Sfmt 4703
Background and Brief Description
Section 2(a) of Pub. L. 102–493
(known as the Fertility Clinic Success
Rate and Certification Act of 1992
(FCSRCA), 42 U.S.C. 263a–1(a)) requires
E:\FR\FM\13JAN1.SGM
13JAN1
1689
Federal Register / Vol. 74, No. 8 / Tuesday, January 13, 2009 / Notices
that each assisted reproductive
technology (ART) program shall
annually report to the Secretary through
the Centers for Disease Control and
Prevention: (1) Pregnancy success rates
achieved by such ART program, and (2)
the identity of each embryo laboratory
used by such ART program and whether
the laboratory is certified or has applied
for such certification under the Act. The
required information is currently
reported by ART programs to CDC as
specified in the Assisted Reproductive
Technology (ART) Program Reporting
System (OMB No. 0920–0556, exp. 9/
30/2009). CDC seeks to extend OMB
approval for a period of three years and
incorporate a minor change in wording
to one question. In addition, the revised
total burden estimate includes an
anticipated increase in the number of
respondents and a slight decrease in the
average number of responses per
respondent. The burden estimate per
response has also been revised to
include an adjustment for data
validation procedures.
The currently approved program
reporting system, also known as the
National ART Surveillance System
(NASS), includes information about all
ART cycles initiated by any of the ART
programs in the United States. An ART
cycle is considered to begin when a
woman begins taking ovarian
stimulatory drugs or starts ovarian
monitoring with the intent of having
embryos transferred. The system also
collects information about the
pregnancy outcome of each cycle, as
well as a number of data items deemed
important to explain variability in
success rates across ART programs and
across individuals. Data elements and
definitions currently in use reflect
CDC’s consultations with
representatives of the Society for
Assisted Reproductive Technology
(SART), the American Society for
Reproductive Medicine, and RESOLVE,
the National Infertility Association (a
national, nonprofit consumer
organization), as well as a variety of
individuals with expertise and interest
in this field.
Respondents are the 480 ART
programs in the United States.
Approximately 420 clinics are expected
to report an average of 286 ART cycles
each. Ten percent of responding clinics
will be randomly selected to participate
in full validation of selected ART cycle
records and an abbreviated validation of
selected cycles resulting in live birth.
All information is collected
electronically. Respondents have the
option of entering data directly into a
Web-based NASS interface or of
transmitting system-compatible files
extracted from other record systems.
The ART program reporting system
allows CDC to publish an annual report
to Congress as specified by the FCSRCA
and to provide information needed by
consumers.
There are no costs to respondents
other than their time.
ESTIMATED ANNUALIZED BURDEN HOURS
Respondents
Form name
ART Programs ......................................
Number of
respondents
NASS ....................
Dated: January 2, 2009.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E9–405 Filed 1–12–09; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Subcommittee on Procedures
Reviews, Advisory Board on Radiation
and Worker Health (ABRWH), National
Institute for Occupational Safety and
Health (NIOSH)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention, announces the
following meeting for the
aforementioned subcommittee:
Time and Date: 9:30 a.m.–5 p.m., January
28, 2009.
Place: Cincinnati Airport Marriott, 2395
Progress Drive, Hebron, Kentucky 41018.
Telephone (859) 334–4611, Fax (859) 334–
4619.
Status: Open to the public, but without a
public comment period. To access by
VerDate Nov<24>2008
19:10 Jan 12, 2009
Jkt 217001
Number of
responses per
respondent
420
286
conference call dial the following
information 1(866) 659–0537, Participant
Pass Code 9933701.
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation Program
Act of 2000 to advise the President on a
variety of policy and technical functions
required to implement and effectively
manage the new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
probability of causation guidelines that have
been promulgated by the Department of
Health and Human Services (HHS) as a final
rule; advice on methods of dose
reconstruction which have also been
promulgated by HHS as a final rule; advice
on the scientific validity and quality of dose
estimation and reconstruction efforts being
performed for purposes of the compensation
program; and advice on petitions to add
classes of workers to the Special Exposure
Cohort (SEC).
In December 2000, the President delegated
responsibility for funding, staffing, and
operating the Advisory Board to HHS, which
subsequently delegated this authority to CDC.
NIOSH implements this responsibility for
CDC. The charter was issued on August 3,
2001, renewed at appropriate intervals, and
will expire on August 3, 2009.
Purpose: The Advisory Board is charged
with (a) Providing advice to the Secretary,
HHS, on the development of guidelines
under Executive Order 13179; (b) providing
advice to the Secretary, HHS, on the
PO 00000
Frm 00028
Fmt 4703
Sfmt 4703
Average burden
per response
(in hours)
38/60
Total burden
(in hours)
76,076
scientific validity and quality of dose
reconstruction efforts performed for this
program; and (c) upon request by the
Secretary, HHS, advise the Secretary on
whether there is a class of employees at any
Department of Energy facility who were
exposed to radiation but for whom it is not
feasible to estimate their radiation dose, and
on whether there is reasonable likelihood
that such radiation doses may have
endangered the health of members of this
class. The Subcommittee on Procedures
Reviews was established to aid the Advisory
Board in carrying out its duty to advise the
Secretary, HHS, on dose reconstruction. It
will be responsible for overseeing, tracking,
and participating in the reviews of all
procedures used in the dose reconstruction
process by the NIOSH Office of
Compensation Analysis and Support (OCAS)
and its dose reconstruction contractor.
Matters To Be Discussed: The agenda for
the Subcommittee meeting includes: a
discussion of proposed new versions of the
computer-assisted telephone interview
scripts and procedures NIOSH uses to
interview claimants at the outset of the dose
reconstruction process; a discussion of
ORAUT–OTIB–0054 (‘‘Fission and
Activation Product Assignment for Internal
Dose-Related Gross Beta and Gross Gamma
Analyses’’) and ORAUT–OTIB–0066
(‘‘Calculation of Dose from Intakes of Special
Tritium Compounds’’); and, a continuation of
the comment-resolution process for other
dose reconstruction procedures under review
by the Subcommittee.
E:\FR\FM\13JAN1.SGM
13JAN1
]]>Agencies
[Federal Register Volume 74, Number 8 (Tuesday, January 13, 2009)]
[Notices]
[Pages 1688-1689]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-405]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60 Day-09-0556]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call 404-639-5960
and send comments to Maryam I. Daneshvar, CDC Acting Reports Clearance
Officer, 1600 Clifton Road, MS-D74, Atlanta, GA 30333 or send an e-mail
to omb@cdc.gov.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology. Written comments should be received
within 60 days of this notice.
Proposed Project
Assisted Reproductive Technology (ART) Program Reporting System--
Revision--National Center for Chronic Disease Prevention and Health
Promotion (NCCDPHP), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
Section 2(a) of Pub. L. 102-493 (known as the Fertility Clinic
Success Rate and Certification Act of 1992 (FCSRCA), 42 U.S.C. 263a-
1(a)) requires
[[Page 1689]]
that each assisted reproductive technology (ART) program shall annually
report to the Secretary through the Centers for Disease Control and
Prevention: (1) Pregnancy success rates achieved by such ART program,
and (2) the identity of each embryo laboratory used by such ART program
and whether the laboratory is certified or has applied for such
certification under the Act. The required information is currently
reported by ART programs to CDC as specified in the Assisted
Reproductive Technology (ART) Program Reporting System (OMB No. 0920-
0556, exp. 9/30/2009). CDC seeks to extend OMB approval for a period of
three years and incorporate a minor change in wording to one question.
In addition, the revised total burden estimate includes an anticipated
increase in the number of respondents and a slight decrease in the
average number of responses per respondent. The burden estimate per
response has also been revised to include an adjustment for data
validation procedures.
The currently approved program reporting system, also known as the
National ART Surveillance System (NASS), includes information about all
ART cycles initiated by any of the ART programs in the United States.
An ART cycle is considered to begin when a woman begins taking ovarian
stimulatory drugs or starts ovarian monitoring with the intent of
having embryos transferred. The system also collects information about
the pregnancy outcome of each cycle, as well as a number of data items
deemed important to explain variability in success rates across ART
programs and across individuals. Data elements and definitions
currently in use reflect CDC's consultations with representatives of
the Society for Assisted Reproductive Technology (SART), the American
Society for Reproductive Medicine, and RESOLVE, the National
Infertility Association (a national, nonprofit consumer organization),
as well as a variety of individuals with expertise and interest in this
field.
Respondents are the 480 ART programs in the United States.
Approximately 420 clinics are expected to report an average of 286 ART
cycles each. Ten percent of responding clinics will be randomly
selected to participate in full validation of selected ART cycle
records and an abbreviated validation of selected cycles resulting in
live birth. All information is collected electronically. Respondents
have the option of entering data directly into a Web-based NASS
interface or of transmitting system-compatible files extracted from
other record systems. The ART program reporting system allows CDC to
publish an annual report to Congress as specified by the FCSRCA and to
provide information needed by consumers.
There are no costs to respondents other than their time.
Estimated Annualized Burden Hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
Number of Average burden
Respondents Form name Number of responses per per response (in Total burden (in
respondents respondent hours) hours)
--------------------------------------------------------------------------------------------------------------------------------------------------------
ART Programs................................ NASS.......................... 420 286 38/60 76,076
--------------------------------------------------------------------------------------------------------------------------------------------------------
Dated: January 2, 2009.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for Disease Control and
Prevention.
[FR Doc. E9-405 Filed 1-12-09; 8:45 am]
BILLING CODE 4163-18-P
